156
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 59-65 | Received 23 Dec 2022, Accepted 07 Sep 2023, Published online: 03 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.